Drugmaker AbbVie chooses North Carolina for $1.4B manufacturing campus
BioPharma Dive
The 185-acre site will be the company s largest single investment to date, with a focus on small-volume parenteral products like vials and prefilled syringes.
pharminent
April 23, 2026 (Last updated: April 24, 2026)
BioPharma Dive
The 185-acre site will be the company s largest single investment to date, with a focus on small-volume parenteral products like vials and prefilled syringes.
